Evidence map›Paper›PMID 38012800›Full record

ArticleOne health outlook2023

Rift valley fever outbreak in Sembabule District, Uganda, December 2020.

Freda Loy Aceng, Joshua Kayiwa, Peter Elyanu, Joseph Ojwang, Luke Nyakarahuka, Stephen Balinandi, Jayne Byakika-Tusiime, Alfred Wejuli, Julie Rebecca Harris, John Opolot

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in One health outlook, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Freda Loy AcengDepartment of Integrated Epidemiology, Surveillance and Public Health Emergencies, Ministry of Health, Kampala, Uganda. faceng@musph.ac.ug.ORCID http://orcid.org/0000-0003-3029-8947
Joshua KayiwaDepartment of Integrated Epidemiology, Surveillance and Public Health Emergencies, Ministry of Health, Kampala, Uganda.
Peter ElyanuBaylor College of Medicine - Children's Foundation, Kampala, Uganda.
Joseph OjwangDivision of Global Health Protection, Centers for Disease Control and Prevention, Kampala, Uganda.
Luke NyakarahukaUganda Virus Research Institute, Entebbe, Uganda.
Stephen BalinandiUganda Virus Research Institute, Entebbe, Uganda.
Jayne Byakika-TusiimeWorld Health Organization, Kampala, Uganda.
Alfred WejuliDepartment of Integrated Epidemiology, Surveillance and Public Health Emergencies, Ministry of Health, Kampala, Uganda.
Julie Rebecca HarrisDivision of Global Health Protection, Centers for Disease Control and Prevention, Kampala, Uganda.
John OpolotDepartment of Integrated Epidemiology, Surveillance and Public Health Emergencies, Ministry of Health, Kampala, Uganda.
Ministry of Health · UGCenters for Disease Control and Prevention · UGUganda Virus Research Institute · UGBaylor College of Medicine Children’s Foundation · UGWorld Health Organization - Uganda · UG

Funding

Medical Research Council MC_UU_00033/1World Health Organization 001
6 · The paper itself

Abstract

backgroundRift Valley Fever (RVF) is a viral zoonosis that can cause severe haemorrhagic fevers in humans and high mortality rates and abortions in livestock. On 10 December 2020, the Uganda Ministry of Health was notified of the death of a 25-year-old male who tested RVF-positive by reverse-transcription polymerase chain reaction (RT-PCR) at the Uganda Virus Research Institute. We investigated to determine the scope of the outbreak, identify exposure factors, and institute control measures.

methodsA suspected case was acute-onset fever (or axillary temperature > 37.5 °C) and ≥ 2 of: headache, muscle or joint pain, unexpected bleeding, and any gastroenteritis symptom in a resident of Sembabule District from 1 November to 31 December 2020. A confirmed case was the detection of RVF virus nucleic acid by RT-PCR or serum IgM antibodies detected by enzyme-linked immunosorbent assay (ELISA). A suspected animal case was livestock (cattle, sheep, goats) with any history of abortion. A confirmed animal case was the detection of anti-RVF IgM antibodies by ELISA. We took blood samples from herdsmen who worked with the index case for RVF testing and conducted interviews to understand more about exposures and clinical characteristics. We reviewed medical records and conducted an active community search to identify additional suspects. Blood samples from animals on the index case's farm and two neighbouring farms were taken for RVF testing.

resultsThe index case regularly drank raw cow milk. None of the seven herdsmen who worked with him nor his brother's wife had symptoms; however, a blood sample from one herdsman was positive for anti-RVF-specific IgM and IgG. Neither the index case nor the additional confirmed case-patient slaughtered or butchered any sick/dead animals nor handled abortus; however, some of the other herdsmen did report high-risk exposures to animal body fluids and drinking raw milk. Among 55 animal samples collected (2 males and 53 females), 29 (53%) were positive for anti-RVF-IgG.

conclusionsTwo human RVF cases occurred in Sembabule District during December 2020, likely caused by close interaction between infected cattle and humans. A district-wide animal serosurvey, animal vaccination, and community education on infection prevention practices campaign could inform RVF exposures and reduce disease burden.

Indexed as

One healthOutbreakRift Valley FeverSembabuleUgandaZoonoses

Identifiers

PMID38012800
PMCPMC10680244
OpenAlexW4389049642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.